Document 0052
 DOCN  M9650052
 TI    [Vaginal and intrauterine contraception]
 DT    9605
 AU    Serfaty D; Centre de regulation des naissances Hopital, Saint-Louis,;
       Paris.
 SO    Rev Prat. 1995 Dec 1;45(19):2407-15. Unique Identifier : AIDSLINE
       MED/96148041
 AB    Vaginal contraception (condom, diaphragm and spermicide in pessary,
       tablet, jelly, cream, or sponge form) have been little used in France
       and generally in Europe since the advent of modern contraception with
       the pill and the intrauterine contraceptive device. The former methods,
       when properly used, are nevertheless both effective and useful, at least
       as interim measures. In addition, the protection they afford against
       sexually transmitted diseases and, for the condom, against HIV, is not
       negligible. Finally, the barrier methods of contraception such as the
       diaphragm and the condom afford significant protection against cancer of
       the cervix. The intrauterine contraceptive device (IUCD), used in France
       by 14% of women between 15 and 49 years of age and by 90 million women
       throughout the world for whom it is the main reversible means of
       contraception, have a mechanism of action that is still not fully
       understood. Most IUCD now used are made of copper. There are also
       diffusion IUCD based on progesterone or a synthetic progestational
       hormone which are useful in case of anaemia, menorrhagia or
       dysmenorrhea.
 DE    Administration, Intravaginal  Contraceptive Agents/*ADMINISTRATION &
       DOSAGE/CONTRAINDICATIONS  Contraceptive
       Devices/*CLASSIFICATION/CONTRAINDICATIONS  English Abstract  Female
       Human  *Intrauterine Devices  Male  JOURNAL ARTICLE  REVIEW  REVIEW,
       MULTICASE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).